Who owns ADMA BIOLOGICS, INC. (ADMA)? Elite investor 13F holders
7 tracked elite investors reported holding ADMA BIOLOGICS, INC as of 2026-06-30, including Rubric Capital, Caligan Partners, D.E. Shaw, Duquesne Family Office, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rubric Capital | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 78170895.00 USD | 9339414.000000 | Shares | add | Original filing |
| Caligan Partners | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 47918309.00 USD | 5725007.000000 | Shares | add | Original filing |
| D.E. Shaw | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 44148376.00 USD | 5274597.000000 | Shares | add | Original filing |
| Duquesne Family Office | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 23303000.00 USD | 2784110.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 5461676.00 USD | 652530.000000 | Shares | reduce | Original filing |
| Tudor Investment | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Bridgewater Associates | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3356864.00 USD | 401059.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | ADMA BIOLOGICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 617949.00 USD | 73829.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.